home / stock / sttk / sttk news

STTK News and Press, Shattuck Labs Inc. From 01/05/26

Stock Information
Company Name: Shattuck Labs Inc.
Stock Symbol: STTK
Market: NASDAQ
Website: shattucklabs.com
Menu
STTK STTK Quote STTK Short STTK News STTK Articles STTK Message Board
Get STTK Alerts

News, Short Squeeze, Breakout and More Instantly...
STTK - Why Shattuck Labs Stock Soared in December

2026-01-05 22:50:09 ET A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (NASDAQ: STTK) stock in 2025's final month. The clinical-stage biotech 's share price rose by almost 74% as a result. The person responsible for that i...
STTK - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AUSTIN, TX and DURHAM, NC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily rece...

STTK - Shattuck Labs to Participate in Upcoming December Investor Conferences

AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily rece...

STTK - Shattuck Labs GAAP EPS of -$0.14

2025-11-07 08:32:44 ET More on Shattuck Labs Shattuck Labs, Inc. (STTK) Presents At The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript Shattuck Labs GAAP EPS of -$0.24 in-line Seeking Alpha’s Quant Rating on Shattuck Labs Hist...
STTK - Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights

–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – Appointments of Dan Baker, M.D., and Mona Ashiya, Ph.D. to the Bo...

STTK - Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

2025-10-10 21:16:39 ET Shattuck Labs, Inc. (STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT... Read the full article on Seeking Alpha For further details see: Shattuck Labs, Inc. (STTK) Presents at The United European Gast...

STTK - Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel

AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immu...
STTK - Absci Corporation: ABS-101 Has Both First-Gen And Next-Gen Competitors

2025-09-17 06:08:57 ET ... Read the full article on Seeking Alpha For further details see: Absci Corporation: ABS-101 Has Both First-Gen And Next-Gen Competitors

STTK - PRISM Mid-Day Movers: Share Purchases and Wearables Innovation Drive Index Gains

2025-09-03 13:30:25 ET Shattuck Labs Jumps 26% on OrbiMed Investment Shattuck Labs, Inc. ( STTK ) surged 26.24% to lead the PRISM Emerging Biotech Index after OrbiMed Advisors disclosed the purchase of over 6.3 million shares at $0.8677 per share , totaling $5.47 million. ...

STTK - US Companies Moving the Markets, Morning edition
Wed, Sep 03, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Nuburu Inc. (BURU) rose 21.9% to $0.1974 on volume of 100,839,011 shares Opendoor Technologies Inc (OPEN) rose 0.7% to $5.1274 on volume of 57,480,214 shares BT Brands Inc. (BTBD) rose 116.8% to $4.0109 on volume of 53,345,044 shares ...
Previous 10 Next 10